Archive | Video Reports

Tebentafusp for Uveal Melanoma: Cytokine Release Syndrome

Richard D. Carvajal, MD: The other big category of toxicity is the cytokine release syndrome [CRS]-type symptoms.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports

Uveal Melanoma: Current Treatment Approaches

Richard D. Carvajal, MD: Hello, my name is Richard Carvajal. I’m a medical oncologist at Columbia University Irving Medical Center in New York, New York.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports

Tebentafusp Efficacy Data in Uveal Melanoma

Richard D. Carvajal, MD: We’ve had 2 dedicated clinical trials now for the uveal melanoma patient population, the 102 trial and then the 202 trial.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports

Tebentafusp for Uveal Melanoma

Richard D. Carvajal, MD: Let’s shift gears to tebentafusp, an immunotherapy where there is clear success. I wonder if you can describe for the audience how this drug works? What’s its mechanism?

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports